PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
3.85%
Some net income increase while QCOM is negative at -17.06%. John Neff would see a short-term edge over the struggling competitor.
-0.82%
Negative yoy D&A while QCOM is 7.37%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
136.36%
Some yoy growth while QCOM is negative at -64.67%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
45.24%
SBC growth well above QCOM's 25.24%. Michael Burry would flag major dilution risk vs. competitor’s approach.
-179.62%
Negative yoy working capital usage while QCOM is 106.28%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
-672.73%
AR is negative yoy while QCOM is 93.44%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
-44.44%
Negative yoy inventory while QCOM is 128.31%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
2200.00%
A yoy AP increase while QCOM is negative at -20.37%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
-204.79%
Both reduce yoy usage, with QCOM at -68.10%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
97.80%
Some yoy increase while QCOM is negative at -373.33%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
-12.94%
Negative yoy CFO while QCOM is 82.37%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-45.28%
Both yoy lines negative, with QCOM at -34.77%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-100.00%
Both yoy lines negative, with QCOM at -430.77%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
-18.33%
Both yoy lines negative, with QCOM at -64.69%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
26.02%
Proceeds from sales/maturities above 1.5x QCOM's 12.73%. David Dodd would confirm if the firm is capitalizing on strong valuations or freeing liquidity for expansions.
91.81%
Less 'other investing' outflow yoy vs. QCOM's 241.38%. David Dodd would see a stronger short-term cash position unless competitor invests more wisely.
-11.35%
Both yoy lines negative, with QCOM at -255.62%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
-10.00%
Both yoy lines negative, with QCOM at -4.87%. Martin Whitman suspects an environment prompting net new borrowings or weaker paydowns across the niche.
71.93%
We slightly raise equity while QCOM is negative at -100.00%. John Neff sees competitor possibly preserving share count or buying back shares.
-566.67%
We cut yoy buybacks while QCOM is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.